menu
    • menu

    Company profile for Carrick Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Carrick Therapeutics’ aim is to create the leading European based oncology company. The name Carrick means ‘rock’ in Irish to emphasize our strong foundation of like-minded scientists, collaborators and investors, and the vision to build a durable world-class company. Carrick Therapeutics has an ambitious patient focused vision to serve cancer patients around the world by the introduction of ground breaking cancer therap...
    Carrick Therapeutics’ aim is to create the leading European based oncology company. The name Carrick means ‘rock’ in Irish to emphasize our strong foundation of like-minded scientists, collaborators and investors, and the vision to build a durable world-class company. Carrick Therapeutics has an ambitious patient focused vision to serve cancer patients around the world by the introduction of ground breaking cancer therapies that will transform the way cancer is treated.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Carrick TherapeuticsIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    NovaUCD Belfield Innovation Park University College Dublin Belfield Dublin 4
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.carricktherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Carrick Therapeutics Reports Phase 2 Trial Success
    Carrick Therapeutics Reports Phase 2 Trial Success

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203450/0/en/Carrick-Therapeutics-Announces-Positive-Results-from-Phase-2-Randomized-Trial-of-Samuraciclib-in-Combination-with-Fulvestrant-in-Patients-with-Hormone-Receptor-Positive-HER2-Negati.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Carrick Therapeutics: New Data on Samuraciclib in Breast Cancer
    Carrick Therapeutics: New Data on Samuraciclib in Breast Cancer

    15 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/15/3081965/0/en/Carrick-Therapeutics-Announces-New-Clinical-Data-Supporting-Biomarker-driven-Patient-Selection-for-Samuraciclib-CDK7i-in-Combination-with-SERDs-in-Hormone-Receptor-Positive-Advance.html

    GLOBENEWSWIRE
    15 May 2025
    Share Share
    Carrick Doses First Patient In CT7439 Phase 1 Trial
    Carrick Doses First Patient In CT7439 Phase 1 Trial

    23 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/23/2951333/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-CT7439-CDK12-13-Inhibitor.html

    GLOBENEWSWIRE
    23 Sep 2024
    Share Share
    Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
    Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts

    05 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/05/2893782/0/en/Carrick-Therapeutics-Establishes-New-Headquarters-in-Boston-Massachusetts.html

    GLOBENEWSWIRE
    05 Jun 2024
    Share Share
    Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib
    Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib

    14 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/14/2829038/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share
    Carrick Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib
    Carrick Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib

    15 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/15/2797014/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2b-Clinical-Trial-of-Samuraciclib-in-Combination-with-Fulvestrant-in-Patients-with-Advanced-HR-HER2-Breast-Cancer.html

    GLOBENEWSWIRE
    15 Dec 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search